Introduction
Since Gottlieb et al. [2009] published some intriguing sequence differences between DNA obtained from abdominal aortic (AA) tissue and blood, the scientific community has been attempting to understand their findings. Dr. Gottlieb's group was primarily interested in performing case-control association analyses in abdominal aortic aneurysm (AAA) patients.
However, instead of obtaining a significant association, they realized that both diseased and nondiseased AA tissues contained polymorphisms which were not observed in the matching blood samples. Dr. Hatchwell [2010] has proposed that the BAK1 gene variants were likely due to sequencing of a processed gene on chromosome 20. However, in response, Dr. Gottlieb and coauthors [2010] have argued that "some but not all of the sequence changes present in the BAK1 sequence of our abdominal aorta samples are also present in the chromosome 20 BAK1 sequence. However, all the AAA and AA cDNA samples are identical to each other and different from chromosome 20 BAK1 sequence at amino acids 2 and 145". I have been following this discussion because I have independently reached almost the same conclusion as Dr. Hatchwell did [Yamagishi, 2009] , and, unfortunately, the response from Dr. Gottlieb and his co-authors seems to me to be unsatisfactory for the reasons listed below.
Sequence Inconsistencies
The core of their argument is that "some but not all of the sequence changes present in the BAK1 sequence of our abdominal aorta samples are also present in the chromosome 20 BAK1 sequence". Actually, there are 11 Single Nucleotide Polymorphisms (SNPs) as illustrated in Figure 1 . However, they have picked only two previously not reported SNPs to support their argument. The problem is that the BAK1 sequence inferred from their Table 2 (third row) of their original paper does not seem to be the BAK1 refseq NM_001188.3 either. If they did not make multiple independent typographical errors, their BAK1 sequence differs from refseq NM_001188.3 in at least four codons as shown in Table 1 . For instance, the 28 th amino acid codon in their sequence is GTC which is mis-translated as ALA instead of VAL, while in sequence NM_001188.3 the codon is GCC (ALA) as is shown in Figure 1 . The 42 nd amino acid codon, CGC, is really problematic, for in refseq NM_001188.3 it is supposed to code for ARG, while in BAK1 on chromosome 20 the codon is CAC which codes for HIS. It occurs that in their 
Primer Design
Gottlieb et al. used "BAK1-specific primers" to amplify AAA and AA samples; however, It is true that Gottlieb et al., in their response, explicitly affirm that they have used intronspecific primers to amplify BAK1 exon 3 on AAA and AA tissue samples; however, from the text of the original article one was led to believe that they were using the non-specific primers.
Thus, the primer design must be completely described, otherwise it is not possible to understand the results, much less the possible explanations.
Concerning the amplification of the matching blood samples, Gottlieb et al. indeed used BAK1 on chromosome 6 (exons) intron-specific primers; however, these samples are not in agreement with BAK1 refseq NM_001188.3 at least in amino acid codons 28, 42, 52 and 103 as shown in Table 1 .
Other Issues
In their response, Gottlieb et al. [2010] Finally, an experiment to determine the truth might consist of the use of intron-specific primers to the chromosome 6 BAK1 whole set of exons on AAA and AA samples. I believe that this is the definitive experiment.
